Well-rounded Market Access Executive with a demonstrated history of working in the Medical Device and Biologics industry. Specializing in launch strategy of emergent technology (with Miscellaneous/NOC Coding) pertaining to clinical and economic Payer education and execution of Provider/Institution Reimbursement Pull-through.Skilled in: -Medical Policy Development, ongoing Clinical Review, Medical Society and Academic advocacy for Policy Influence. -MAC LCD oversight, application and translation to Providers and Institutions, LCD Reconsideration Process. -Provider/Institutional Billing and Coding Protocol for appropriate Reimbursement in line with Medical Policy.-Payer Contracting and Rebating strategy to expand Portfolio Access.Therapeutic areas include: Oncology, ENT Surgery, Interventional Vascular and Oncologic Surgery, Neurology, Endocrinology, Cardiology. Well-networked Managed Markets professional with a sales foundation in Buy & Bill Biotech and Device.